A new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease.
Infants less than 6 months who have chronic lung disease or other underlying conditions should be given priority, the Centers for Disease Control and Prevention told doctors in a Monday evening advisory.
The new, one-time shot is a lab-made antibody that helps the immune system fight off the virus. Sold under the brand name Beyfortus, the drug was developed by AstraZeneca and Sanofi. It comes in prefilled syringes in doses of 50 milligrams or 100 milligrams. The larger doses are for larger, heavier infants.
In a statement, Sanofi said demand - especially for the larger doses - “has been higher than anticipated.”
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
A new shot for RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
Baca lebih lajut »
A new RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease.
Baca lebih lajut »
A new RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
Baca lebih lajut »
CDC updates RSV shot recommendations due to drug shortagesThe Centers for Disease Control and Prevention issued a health alert Monday in response to limited supplies of an antibody drug designed to protect infants from the respiratory disease RSV.
Baca lebih lajut »
CDC Warns of Shortage of RSV Shots to Protect BabiesDemand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants. In an alert posted Monday afternoon, the U.S. Centers for Disease Control and...
Baca lebih lajut »
CDC updates RSV shot recommendations due to drug shortagesThe agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
Baca lebih lajut »